SCHEMBL371018

SCHEMBL371018

COCc1c(-c2csc(N)n2)cnn1S(=O)(=O)c1ccc(OC)cc1

nearest known ligand 0.44

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.44
ALDH1A1 P00352 5/20 0.44
SMN1; SMN2 Q16637 4/20 0.44
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
POLB P06746 2/20 0.44
KDM4E B2RXH2 3/20 0.43
THRB P10828 1/20 0.43
LTA4H P09960 1/20 0.42
KMT2A Q03164 6/20 0.40
MEN1 O00255 5/20 0.40
CXCL8 P10145 1/20 0.37
NOD1 Q9Y239 1/20 0.37
LMNA P02545 2/20 0.37
CTSB P07858 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL370317 0.78 LTA4H (0.50) MAPTALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL30755188 0.65 HTR6 (0.49) MAPTALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL370629 0.65 LTA4H (0.50) MAPTALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL2379499 0.64 ALDH1A1 (0.52) MAPTALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL127807 0.64 RAB9A (1.00) MAPTALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL2762813 0.63 RAB9A (0.66) MAPTALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL27986462 0.63 ALDH1A1 (0.58) MAPTALDH1A1SMN1; SMN2NPC1RAB9A
Bromide SCHEMBL8355367 0.63 RAB9A (0.96) MAPTALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL24107434 0.61 HSD17B10 (0.53) MAPTALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL5327111 0.61 ALDH1A1 (0.71) MAPTALDH1A1SMN1; SMN2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2595986-A2 NOVEL 2-AMINO-4-PYRAZOLYL-THIAZOLE DERIVATIVES AND THEIR USE AS ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS Addex Pharma SA (CH) 2013-05-29 EP disclosed
WO-2012009009-A2 NOVEL 2-AMINO-4-PYRAZOLYL-THIAZOLE DERIVATIVES AND THEIR USE AS ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS ADDEX PHARMA S.A. (CH) 2012-01-19 WO disclosed